InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,130.00
(
-4.57%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
75.65
(
-1.91%
)
Bitcoin
51,499.38
(
-10.98%
)
Post# of 331426
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pix

Send PM Follow Ignore
Followers 12
Posts 473
Boards Moderated 0
Alias Born 06/01/2009

pix

Re: None

Wednesday, 04/26/2017 1:32:13 PM

Wednesday, April 26, 2017 1:32:13 PM

Post# of 331426
The focus on Opioid Epidemic is just right. They now need to bring up a well designed and powered study to show the Product to reduce the use of Opioids in a meaningful patient cohort.

Such a study, granted it reaches the primary endpoint, would for sure bring in the desired partner/licensee.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM

POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM

Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM

VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM

Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM

Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!